Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development

Molecular and Cellular Endocrinology

Volumn 207, Issue 1-2, 2003, Pages 13-20

  Kuchenbauer, F ^a   Theodoropoulou, M ^a   Hopfner, U ^a   Stalla, J ^a   Renner, U ^a   Tonn, J C ^b   Low, M J ^c   Arzt, E ^d,e   Stalla, G K ^a   Paez Pereda M ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d INSTITUTO DE FISIOLOGÍA   (Argentina)

^e Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Extracellular matrix; Laminin; Pituitary neoplasm; Prolactin

Indexed keywords

DOPAMINE 2 RECEPTOR; LAMININ; PROLACTIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; HYPERPLASIA; HYPOPHYSIS; HYPOPHYSIS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SECRETING CELL; PROLACTIN SYNTHESIS; PROLACTINOMA; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; TISSUE DISTRIBUTION; TUMOR CELL; WILD TYPE;

EID: 10744231725     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(03)00237-5     Document Type: Article

References (36)

1. Arzt E., Stelzer G., Renner U., Lange M., Muller O.A., Stalla G.K. Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J. Clin. Invest. 90:1992;1944-1951.
2. Asa S.L., Kelly M.A., Grandy D.K., Low M.J. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology. 140:1999;5348-5355.
3. Aumailley M., Gayraud B. Structure and biological activity of the extracellular matrix. J. Mol. Med. 76:1998;253-265.
4. Aumailley M., Krieg T. Laminins: a family of diverse multifunctional molecules of basement membranes. J. Invest. Dermatol. 106:1996;209-214.
5. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science. 276:1997;1425-1428.
6. De Arcangelis A., Neuville P., Boukamel R., Lefebvre O., Kedinger M., Simon-Assmann P. Inhibition of laminin alpha 1-chain expression leads to alteration of basement membrane assembly and cell differentiation. J. Cell Biol. 133:1996;417-430.
7. de Carvalho D.F., Silva K.L., de Oliveria D.A., Villa-Verde D.M., Coelho H.S., Silva L.C., Nasciutti L.E. Characterization and distribution of extracellular matrix components and receptors in GH3B6 prolactin cells. Biol. Cell. 92:2000;351-362.
8. De lorio P., Midulla C., Pisani T., Valli C., Grillo L., Di Cocco B., Nofroni I., Vecchione A. Implication of laminin and collagen type IV expression in the progression of breast carcinoma. Anticancer Res. 21:2001;1395-1399.
9. Denduchis B., Rettori V., McCann S.M. Role of laminin on prolactin and gonadotrophin release from anterior pituitaries of male rats. Life Sci. 55:1994;1757-1765.
10. Elias K.A., Weiner R.I., Mellon S.H. Effect of extracellular matrix on prolactin secretion and mRNA accumulation in GH3 cells. DNA Cell Biol. 9:1990;369-375.
11. Farnoud M.R., Lissak B., Kujas M., Peillon F., Racadot J., Li J.Y. Specific alterations of the basement membrane and stroma antigens in human pituitary tumours in comparison with the normal anterior pituitary. An immunocytochemical study. Virchows Arch. Pathol. Anat. Histopathol. 421:1992;449-455.
12. Farnoud M.R., Derome P., Peillon F., Li J.Y. Immunohistochemical localization of different laminin isoforms in human normal and adenomatous anterior pituitary. Lab. Invest. 70:1994;399-406.
13. Farnoud M.R., Veirana N., Derome P., Peillon F., Li J.Y. Adenomatous transformation of the human anterior pituitary is associated with alterations in integrin expression. Int. J. Cancer. 67:1996;45-53.
14. Giannelli G., Antonaci S. Biological and clinical relevance of Laminin-5 in cancer. Clin. Exp. Metastasis. 18:2000;439-443.
15. Heaney A.P., Fernando M., Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J. Clin. Invest. 109:2002;277-283.
16. Horacek M.J., Thompson J.C., Dada M.O., Terracio L. The extracellular matrix components laminin, fibronectin, and collagen IV are present among the epithelial cells forming Rathke's pouch. Acta Anat. (Basel). 147:1993;69-74.
17. Huet C., Pisselet C., Mandon-Pepin B., Monget P., Monniaux D. Extracellular matrix regulates ovine granulosa cell survival, proliferation and steroidogenesis: relationships between cell shape and function. J. Endocrinol. 169:2001;347-360.
18. Kelly M.A., Rubinstein M., Asa S.L., Zhang G., Saez C., Bunzow J.R., Allen R.G., Hnasko R., Ben-Jonathan N., Grandy D.K., Low M.J. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron. 19:1997;103-113.
19. Kitayama J., Nagawa H., Tsuno N., Osada T., Hatano K., Sunami E., Saito H., Muto T. Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow. Br. J. Cancer. 80:1999;1927-1934.
20. Kuchenbauer F., Hopfner U., Stalla J., Arzt E., Stalla G.K., Páez-Pereda M. Extracellular matrix components regulate ACTH production and proliferation in corticotroph tumor cells. Mol. Cell. Endocrinol. 175:2001;141-148.
21. Lamoureux P., Zheng J., Buxbaum R.E., Heidemann S.R. A cytomechanical investigation of neurite growth on different culture surfaces. J. Cell Biol. 118:1992;655-661.
22. Lekmine F., Lausson S., Pidoux E., Segond N., Roos B., Treilhou-Lahille F., Jeanne A. Influence of laminin substratum on cell proliferation and CALC I gene expression in medullary thyroid carcinoma C cell lines. Mol. Cell. Endocrinol. 157:1999;181-189.
23. Martin G.R., Timpl R. Laminin and other basement membrane components. Annu. Rev. Cell. Biol. 3:1987;57-85.
24. Mettouchi A., Klein S., Guo W., Lopez-Lago M., Lemichez E., Westwick J.K., Giancotti F.G. Integrin-specific activation of rac controls progression through the G(1) phase of the cell cycle. Mol. Cell. 8:2001;115-127.
25. Páez-Pereda M., Ledda M.F., Goldberg V., Chervín A., Carrizo G., Molina A., Müller A., Renner U., Podhajcer O., Arzt E., Stalla G.K. High levels of matrix metalloproteinase activity regulate proliferation and hormone secretion in pituitary cells. J. Clin. Endocrinol. Metab. 85:2000;263-269.
26. Páez-Pereda M., Kovalovsky D., Hopfner U., Theodoropoulou M., Pagotto U., Uhl E., Losa M., Stalla J., Grübler Y., Missale C., Arzt E., Stalla G.K. Retinoic acid prevents experimental Cushing's syndrome. J. Clin. Invest. 108:2001;1123-1131.
27. Páez-Pereda M., Giacomini D., Refojo D., Carbia Nagashima A., Hopfner U., Grübler Y., Goya R., Hentges S.T., Low M.J., Holsboer F., Stalla G.K., Arzt E. Involvement of BMP-4 in prolactinoma pathogenesis: BMP-4 is expressed in pituitary prolactinomas and promotes cell growth through a mechanism involving Smad-4 and estrogen receptors. Proc. Natl. Acad. Sci. USA. 100:2003;1034-1039.
28. Pellerin S., Keramidas M., Chambaz E.M., Feige J.J. Expression of laminin and its possible role in adrenal cortex homeostasis. Endocrinology. 138:1997;1321-1327.
29. Renner U., Pagotto U., Arzt E., Stalla G.K. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review. Eur. J. Endocrinol. 135:1996;515-532.
30. Schuff K.G., Hentges S.T., Kelly M.A., Binart N., Kelly P.A., luvone P.M., Asa S.L., Low M.J. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J. Clin. Invest. 110:2002;973-981.
31. Tougard C., Louvard D., Picart R., Tixier-Vidal A. Immunocytochemical localization of laminin in rat anterior pituitary cells in vivo and in vitro. In Vitro Cell Dev. Biol. 21:1985;57-61.
32. Turner H.E., Nagy Z., Esiri M.M., Harris A.L., Wass J.A. Role of matrix metalloproteinase 9 in pituitary tumor behavior. J. Clin. Endocrinol. Metab. 85:2000;2931-2935.
33. Varner J.A., Cheresh D.A. Integrins and cancer. Curr. Opin. Cell Biol. 8:1996;724-730.
34. Vila-Porcile E., Picart R., Tixier-Vidal A., Tougard C. Cellular and subcellular distribution of laminin in adult rat anterior pituitary. J. Histochem. Cytochem. 35:1987;287-299.
35. Woodward T.L., Lu H., Haslam S.Z. Laminin inhibits estrogen action in human breast cancer cells. Endocrinology. 141:2000;2814-2821.
36. Yoshida Y., Hosokawa K., Dantes A., Kotsuji F., Kleinman H.K., Amsterdam A. Role of laminin in ovarian cancer tumor growth and metastasis via regulation of Mdm2 and Bcl-2 expression. Int. J. Oncol. 18:2001;913-921.